ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
Fusion Science and Technology
November 2025
Latest News
X-energy raises $700M in latest funding round
Advanced reactor developer X-energy has announced that it has closed an oversubscribed Series D financing round of approximately $700 million. The funding proceeds are expected to be used to help continue the expansion of its supply chain and the commercial pipeline for its Xe-100 advanced small modular reactor and TRISO-X fuel, according the company.
V. Abella, R. Miró, B. Juste, G. Verdú
Nuclear Technology | Volume 175 | Number 1 | July 2011 | Pages 53-57
Technical Paper | Special Issue on the 16th Biennial Topical Meeting of the Radiation Protection and Shielding Division / Radiation Transport and Protection | doi.org/10.13182/NT11-A12269
Articles are hosted by Taylor and Francis Online.
This work is focused on coupling PLanUNC (PLUNC), a set of software tools for radiotherapy treatment planning (RTP), with MCNP5 Monte Carlo N-Particle transport code, utilizing the RANDO phantom as the patient model and the Elekta Precise linac as the irradiation source for comparison. Thus, the main goal of this paper is to compare the results obtained from the default calculations of the treatment plan software with those obtained via the implementation of MCNP5 calculations. Monte Carlo techniques have been proved to be a more accurate dose calculation aid than conventional treatment planning systems, having the only limitation of computer time. The implementation of MCNP5 calculations in a commercial RTP software aims to provide more accurate dose mapping of the patient in reasonable computer times. The results obtained in this paper represent a significant contribution in the development of RTP patient dose simulations.
